Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00518583 | Phase II Study in Patients With Operable Breast Cancer | unknown | Phase 2 | 30 | Aptium Oncology Research NetworkNETWORK | 1 | Jan 15, 2010 | clinicaltrials |
| NCT00243165 | Lifemel Honey to Reduce Leucopenia During Chemotherapy | unknown | Phase 2 | 60 | Rambam Health Care CampusOTHER | 0 | Dec 7, 2009 | clinicaltrials |
| NCT00875355 |
| Radiation Therapy With or Without Temozolomide in Treating Women With Brain Metastases and Breast Cancer |
| unknown |
| Phase 2 |
| 100 |
| Institut CurieOTHER |
| 1 |
| Aug 26, 2009 |
| clinicaltrials |
| NCT00954135 | Letrozole Plus Oral Cyclophosphamide Plus/Minus Sorafenib as Primary Systemic Treatment in Breast Cancer Patients | unknown | Phase 2 | 190 | University of Turin, ItalyOTHER | 1 | Aug 7, 2009 | clinicaltrials |
| NCT00842998 | Efficacy Study of Single Agent Trastuzumab or Lapatinib to Treat HER2-Overexpressing Breast Cancer(HERLAP) | unknown | Phase 2 | 120 | Azienda Ospedaliera Ordine Mauriziano di TorinoOTHER | 1 | Jun 26, 2009 | clinicaltrials |
| NCT00687648 | Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer | unknown | Phase 2 | 70 | National Cancer Centre, SingaporeOTHER | 1 | Jun 17, 2009 | clinicaltrials |
| NCT00801411 | Cyclophosphamide and Docetaxel or Doxorubicin in Treating Women With Newly Diagnosed Breast Cancer That Can Be Removed by Surgery | unknown | Phase 2 | 318 | National Cancer Centre, SingaporeOTHER | 1 | Jun 17, 2009 | clinicaltrials |
| NCT00003135 | Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer | unknown | Phase 2 | 34 | The University of Texas Health Science Center, HoustonOTHER | 1 | Apr 30, 2009 | clinicaltrials |
| NCT00497458 | Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects(ART2) | unknown | Phase 2 | 90 | Havah Therapeutics Pty LtdINDUSTRY | 1 | Apr 9, 2009 | clinicaltrials |
| NCT00033683 | Combination Chemotherapy in Treating Women With Resected Breast Cancer | unknown | Phase 2 | — | Institute of Cancer Research, United KingdomOTHER | 2 | Feb 9, 2009 | clinicaltrials |
| NCT00077168 | Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole | unknown | Phase 2 | 2,000 | Institute of Cancer Research, United KingdomOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00764972 | Phase IB/II Trial Combining Vinorelbine With Sorafenib as First-Line Treatment in Patients With Metastatic Breast Cancer | unknown | Phase 1 / Phase 2 | 36 | McGill UniversityOTHER | 1 | Oct 21, 2008 | clinicaltrials |
| NCT00669747 | Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS) | unknown | Phase 2 | 45 | Windy Hill Medical, Inc.INDUSTRY | 1 | Oct 2, 2008 | clinicaltrials |
| NCT00717951 | A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast Cancer | unknown | Phase 2 | 120 | Academy Military Medical Science, ChinaINDUSTRY | 0 | Jul 25, 2008 | clinicaltrials |
| NCT00006120 | Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 2 | Jul 24, 2008 | clinicaltrials |
| NCT00010075 | Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00159094 | A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer | unknown | Phase 2 | 30 | Hematology Oncology ConsultantsOTHER | 1 | Jun 2, 2008 | clinicaltrials |
| NCT00434369 | 5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Treating Advanced Breast Cancer Patients | unknown | Phase 2 | 31 | Mast Therapeutics, Inc.INDUSTRY | 5 | Apr 22, 2008 | clinicaltrials |
| NCT00589901 | An All-Oral Combination of Capecitabine and Cyclophosphamide in Patients With Metastatic Breast Cancer (MBC) | unknown | Phase 2 | 60 | Fudan UniversityOTHER | 1 | Apr 18, 2008 | clinicaltrials |
| NCT00501332 | Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy | unknown | Phase 2 | 30 | Maxygen Holdings Ltd.INDUSTRY | 4 | Dec 24, 2007 | clinicaltrials |
| NCT00555516 | A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy | unknown | Phase 1 / Phase 2 | 60 | Tri-Service General Hospital (TSGH)OTHER | 1 | Nov 8, 2007 | clinicaltrials |
| NCT00378638 | Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study | unknown | Phase 2 | 30 | Chap, Linnea I., M.D.INDIV | 1 | Oct 24, 2007 | clinicaltrials |
| NCT00251329 | Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery | unknown | Phase 2 | 48 | Cancer Research NetworkOTHER | 1 | Apr 4, 2007 | clinicaltrials |
| NCT00280930 | Letrozole in Postmenopausal Women at Increased Risk for Breast Cancer | unknown | Phase 2 | 60 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 19, 2007 | clinicaltrials |
| NCT00419900 | Use of Hair to Diagnose the Presence of Breast Cancer | unknown | Phase 1 / Phase 2 | 2,000 | Fermiscan LtdINDUSTRY | 1 | Jan 9, 2007 | clinicaltrials |
| NCT00381368 | Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer Patients | unknown | Phase 2 | 60 | University of TurkuOTHER | 1 | Dec 4, 2006 | clinicaltrials |
| NCT00390377 | Use of Hair to Diagnose Breast Cancer | unknown | Phase 2 | 240 | Fermiscan LtdINDUSTRY | 1 | Oct 19, 2006 | clinicaltrials |
| NCT00337064 | Partial Breast Radiation to the Lumpectomy Cavity With IMRT in Elderly Women | unknown | Phase 1 / Phase 2 | 75 | University of VermontOTHER | 1 | Jun 15, 2006 | clinicaltrials |
| NCT00250874 | Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast Cancer | unknown | Phase 2 | 45 | Zeneus PharmaINDUSTRY | 1 | Nov 8, 2005 | clinicaltrials |
| NCT00006433 | Phase I/II Trial of Doxil and Hyperthermia for Breast Cancer Patients With Chest Wall Recurrence or Stage IV Disease With Locally Advanced Breast Cancer | unknown | Phase 2 | — | National Center for Research Resources (NCRR)NIH | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Jan 15, 2010source: clinicaltrials